---
title: 'A Guide to Implementation Science forÂ Phase 3 Clinical Trialists: Designing
  Trials for Evidence Uptake'
date: '2024-11-06'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39505414/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241107171252&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The delayed and modest uptake of evidence-based treatments following
  cardiovascular clinical trials highlights the need for greater attention to implementation
  early in the development and testing of treatments. However, implementation science
  is not well understood and is often an afterthought following phase 3 trials. In
  this review, we describe the goals, frameworks, and methods of implementation science,
  along with common multilevel barriers and facilitators of implementation. We ...
disable_comments: true
---
The delayed and modest uptake of evidence-based treatments following cardiovascular clinical trials highlights the need for greater attention to implementation early in the development and testing of treatments. However, implementation science is not well understood and is often an afterthought following phase 3 trials. In this review, we describe the goals, frameworks, and methods of implementation science, along with common multilevel barriers and facilitators of implementation. We ...